Bill · S. 2842· Senate(119-S-2842)
Stop CMV Act of 2025
- Introduced
- 9/17/2025
- Last activity
- 9/17/2025 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsored by
- Richard Blumenthal
- Cosponsors
- - 3 - 1
- Introduced
- In Committee
What this bill would do
The "Stop CMV Act of 2025" amends the Public Health Service Act to allow hospitals and health care entities to test infants 21 days old or younger for congenital Cytomegalovirus. State health officers can set the standards for testing, recording results, and educating parents. If a state fails to set these standards within two years, an Advisory Committee will do so. The bill provides grants through the Health Resources and Services Administration and the CDC for testing and technical assistance. Additionally, the National Institutes of Health will research new screening techniques, diagnostics, and treatments.
Yes· 3 of 12
Would children be better off under this?+10
Directly benefits newborns through early screening and potential treatment for a serious congenital virus.
Does this put more money into medical research?+7
The bill mandates the NIH to establish or expand research programs for CMV diagnostics, prevention, and treatments.
Does this put more money into scientific research?+7
The bill specifically authorizes funding and research programs for CMV screening and treatments via the NIH.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Newborn Screening: Hospitals and health care entities can administer tests for congenital Cytomegalovirus to infants 21 days or younger, which helps in identifying the condition early (Sec. 2(a)).
-
Public Education: Grants from the CDC will provide technical assistance to educate health care providers, patients, and the general public on preventing, diagnosing, and treating the virus (Sec. 2(c)(2)(A)(ii)).
-
Medical Research: The National Institutes of Health will fund research into new screening technology, vaccine development, and cures or treatments for the virus both during pregnancy and after birth (Sec. 2(c)(3)(A)).
-
Financial Support: Grants will be awarded to States to help entities administer the required tests (Sec. 2(c)(1)(A)).
Potential Negative Impacts for People
- No negative impacts for individuals or groups are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Children+10Good For People With Disabilities+5Good For Women+5Good For High Income Households+4Good For Low Income Households+4Good For Middle Class Households+4
- Healthcare
- Increases Research Funding+7Improves Healthcare Access+5
- Education And Technology
- Increases Scientific Research Funding+7
- Governance And Ideology
- Increase States Rights+2Increases Federal Power+2
- Social Issues And Justice
- Improves Disability Rights+3
- 3/17/2026
- 1 Cosponsor added.
- 10/14/2025
- 1 Cosponsor added.
- 9/17/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2 Cosponsors added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Amy KlobucharDemocrat · Minnesota
Mark KellyDemocrat · Arizona
Christopher MurphyDemocrat · Connecticut
Roger MarshallRepublican · Kansas